Our AI Workbench enables us to efficiently find therapeutic targets and drug candidates with desirable properties. We are focusing on the discovery of oligonucleotide therapies for genetic disorders. These genetic diseases are mediated by altered molecular phenotypes, such as transcription, splicing, translation or protein binding. Our predictors leverage deep learning to model these molecular phenotypes with high accuracy. This enables us to, in-silico, pin-point the disease-causing genetic mutation(s), identify their molecular consequences, and design oligonucleotides that directly restore the molecular phenotype.